Skip to main content
Neutrophil White Blood Cells

Primary Immune Deficiency (PID)

Have a Question? Use Our New Chat Feature! Chat with our Medical Information Specialists by clicking on the Chat with us now available in the lower right corner of this screen.

Posters

The HILO Study: High Volumes and Flow Rates of Subcutaneous IgPro20 Pump-assisted Infusions in Patients With Primary Immunodeficiency

View Poster

Please see full prescribing information for Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid

Safety Profile of High IgPro20 Infusion Parameters in Patients With Primary Immunodeficiency (PID): Results From the Forced Upward Titration HILO Study

View Poster

Please see full prescribing information for Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid

Feasibility of Subcutaneous IgPro20 Administration Via Manual Push at High Flow Rates in Patients With Primary Immunodeficiency: Findings of the HILO Study

View Poster

Please see full prescribing information for Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid

Immunoglobulin Replacement Therapy in Patients with Immunodeficiencies - Impact of Administration Method on Patient-Reported Outcomes

View Poster

Please see full prescribing information for Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid
Please see full prescribing information for Privigen®, Immune Globulin Subcutaneous (Human), 10% Liquid

High treatment satisfaction with Hizentra, a 20% subcutaneous immunoglobulin (SCIG): Real-world survey data

View Poster

Please see full prescribing information for Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid
Please see full prescribing information for Privigen®, Immune Globulin Subcutaneous (Human), 10% Liquid

Real-world experience of a cohort of previously untreated PI patients on SCIG

View Poster

Please see full prescribing information for Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid
Please see full prescribing information for Privigen®, Immune Globulin Subcutaneous (Human), 10% Liquid

Isoagglutinin Reduction in IVIg by Specific Immunoaffinity Chromatography Reduces Spontaneous Reporting Rates of Hemolytic Reactions

View Poster

Please see full prescribing information for Privigen®, Immune Globulin Subcutaneous (Human), 10% Liquid

Key Publications

For U.S. Healthcare Professionals only
For U.S. Healthcare Professionals only

The purpose of this CSL Behring Medical Affairs website is to support Healthcare Professionals with scientific information. This website is also a channel for U.S. Healthcare Professionals to submit questions or connect with CSL Behring U.S. Healthcare Professionals. The information provided is for educational purposes only and is not intended to promote any products. By continuing to use this site you are acknowledging that you are a US Healthcare Professional

toggle chat overlay
toggle chat overlay